Rapid detection and categorisation of organisms from whole blood in cases of sepsis

动量生物科学的成立是为了在医院微生物实验室内开发临床标本的快速检测，支持全球抗击抗生素耐药性的斗争和改进抗菌素管理的需要。败血症（血液中毒）导致的死亡人数超过了肠癌、乳腺癌和前列腺癌的总和，但败血症的症状往往不具有特异性，导致诊断延误。脓毒症的标准实验室检测是血培养，它可以检测到患者血液中存在的大量细菌，但有时需要几天才能得出结果。我们的研究将着眼于在短短3小时内检测和分类这些细菌的可行性，帮助医生更快地为病人选择正确的抗生素。该项目将探索从血液中捕获和浓缩细菌的新方法，以便使用动量公司已经开发的分子技术检测细菌。

Momentum Bioscience was founded to develop rapid tests for clinical specimens within the hospital microbiology laboratory, supporting the global fight against antibiotic resistance and the need for improved antimicrobial stewardship. Sepsis (blood poisoning) kills more people than bowel, breast and prostate cancer combined but symptoms of sepsis are frequently non-specific, leading to a delay in diagnosis. The standard laboratory test for sepsis is blood culture, which detects a large range of germs that can be found in the patient’s blood but can sometimes take several days to give a result. Our study will look at the feasibility of detecting and categorising these germs in just 3 hours, helping doctors choose the right antibiotic for the patient more quickly. This project will explore new approaches to capturing and concentrating germs from blood so they can be detected using molecular technology already developed by Momentum.